Investor Relations

Economic success ensures medical quality. We pay particular attention to the ability to invest in our existing medical facilities at any time. We are also financially prepared for external growth and can react quickly.

Bild: Asklepios Annual Report 2023

Annual Report 2023

What will the future of medicine be like? How do we manage to be an innovation driver while also staying close to people? With exciting stories and interesting facts, we offer an insight into the past financial year and Asklepios's strategy.

Learn more
Bild: Asklepios Corporate Responsibility Report 2023

Corporate Responsibility Report 2023

As a leading healthcare group, we not only take responsibility for our patients but also for employees, the enviroment, and society. Here you can read about what we have already achieved and what we have undertaken for the future.

Learn more

Latest documents at a glance

IR-News

28.11.2024Asklepios Group: Consistent growth in Q3 2024

06.11.2024Asklepios places its first Social Schuldschein loan of EUR 500.0 million

29.08.2024Asklepios Group: Positive development continued in the first half of 2024 - solid basis for further strategic development

23.05.2024Asklepios Group: Positive business performance in first quarter – Confident outlook for 2024

All notifications

Further Information

Financial reports

Asklepios publishes frequently news and reports about its business and financial development.

Read more

Promissory note loans

Learn more about the key data of our promissory note loans.

Read more

Talk to us

Mirjam Constantin

Mirjam Constantin

Head of Group Reporting (Financial & ESG) | Manager Investor Relations

Share this page